Access cutting-edge pneumococcal infection treatment through this clinical trial at a research site in Topeka. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Topeka location
Preparing your pre-screening questions…
Access pneumococcal infection specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pneumococcal infection treatment provided free
Check if you qualify for this pneumococcal infection clinical trial in Topeka, KS
No-Cost Study Care
Local to Topeka
Convenient for KS residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Researchers are looking for new vaccines to prevent pneumococcal disease, which is any infection in the lungs or other parts of the body that is caused by a type of bacteria called Streptococcus pneumoniae. V118C is a new vaccine designed to help prevent disease from Streptococcus pneumoniae bacteria. This study will look at V118C in toddlers and infants. The goal of the study is to learn how safe V118C is for children and how well they tolerate it.
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT07300267) has an active research site in Topeka, KS that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pneumococcal infection treatment options in Topeka, KS, this clinical trial (NCT07300267) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Topeka research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pneumococcal infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pneumococcal infection clinical trials near you to find additional studies recruiting in your area.
See all prurigo nodularis clinical trials recruiting in Topeka — not just this study.
Browse Prurigo Nodularis Trials in Topeka →